These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 19861693)

  • 1. The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance.
    Pagel-Langenickel I; Bao J; Pang L; Sack MN
    Endocr Rev; 2010 Feb; 31(1):25-51. PubMed ID: 19861693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal muscle mitochondrial dysfunction & diabetes.
    Sreekumar R; Nair KS
    Indian J Med Res; 2007 Mar; 125(3):399-410. PubMed ID: 17496364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans?
    Dumas JF; Simard G; Flamment M; Ducluzeau PH; Ritz P
    Diabetes Metab; 2009 Jun; 35(3):159-67. PubMed ID: 19349201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of mitochondria in insulin resistance and type 2 diabetes mellitus.
    Szendroedi J; Phielix E; Roden M
    Nat Rev Endocrinol; 2011 Sep; 8(2):92-103. PubMed ID: 21912398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial pathophysiology and type 2 diabetes mellitus.
    Garcia-Roves PM
    Arch Physiol Biochem; 2011 Jul; 117(3):177-87. PubMed ID: 21671709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat.
    Warren BE; Lou PH; Lucchinetti E; Zhang L; Clanachan AS; Affolter A; Hersberger M; Zaugg M; Lemieux H
    Am J Physiol Endocrinol Metab; 2014 Mar; 306(6):E658-67. PubMed ID: 24425766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high-fat-diet-induced pre-diabetes.
    Xu D; Jiang Z; Sun Z; Wang L; Zhao G; Hassan HM; Fan S; Zhou W; Han S; Zhang L; Wang T
    J Cell Physiol; 2019 May; 234(5):7510-7523. PubMed ID: 30362548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity is the key determinant of skeletal muscle mitochondrial function in type 2 diabetes.
    van Tienen FH; Praet SF; de Feyter HM; van den Broek NM; Lindsey PJ; Schoonderwoerd KG; de Coo IF; Nicolay K; Prompers JJ; Smeets HJ; van Loon LJ
    J Clin Endocrinol Metab; 2012 Sep; 97(9):3261-9. PubMed ID: 22802091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle mitochondrial content/activity in Type 2 diabetes mellitus.
    Pagel-Langenickel I; Schwartz DR; Arena RA; Minerbi DC; Johnson DT; Waclawiw MA; Cannon RO; Balaban RS; Tripodi DJ; Sack MN
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H2659-66. PubMed ID: 17890427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SIRT1 attenuates high glucose-induced insulin resistance via reducing mitochondrial dysfunction in skeletal muscle cells.
    Zhang HH; Ma XJ; Wu LN; Zhao YY; Zhang PY; Zhang YH; Shao MW; Liu F; Li F; Qin GJ
    Exp Biol Med (Maywood); 2015 May; 240(5):557-65. PubMed ID: 25710929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial dysfunction and type 2 diabetes.
    Parish R; Petersen KF
    Curr Diab Rep; 2005 Jun; 5(3):177-83. PubMed ID: 15929863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and mitochondrial function in skeletal muscle.
    Dela F; Helge JW
    Int J Biochem Cell Biol; 2013 Jan; 45(1):11-5. PubMed ID: 23036788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus.
    Hesselink MK; Schrauwen-Hinderling V; Schrauwen P
    Nat Rev Endocrinol; 2016 Nov; 12(11):633-645. PubMed ID: 27448057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal Muscle Insulin Resistance as a Precursor to Diabetes: Beyond Glucoregulation.
    Greene NP; Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Washington TA
    Curr Diabetes Rev; 2018; 14(2):113-128. PubMed ID: 27875947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin Resistance and Mitochondrial Dysfunction.
    Gonzalez-Franquesa A; Patti ME
    Adv Exp Med Biol; 2017; 982():465-520. PubMed ID: 28551803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of therapeutic strategies targeting mitochondrial biogenesis for the treatment of insulin resistance and type 2 diabetes mellitus.
    Ding W; Yang X; Lai K; Jiang Y; Liu Y
    Arch Pharm Res; 2024 Mar; 47(3):219-248. PubMed ID: 38485900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of mitochondrial biogenesis in metabolic syndrome.
    Rolo AP; Gomes AP; Palmeira CM
    Curr Drug Targets; 2011 Jun; 12(6):872-8. PubMed ID: 21269264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria as a target for exercise-mitigated type 2 diabetes.
    Tian J; Fan J; Zhang T
    J Mol Histol; 2023 Dec; 54(6):543-557. PubMed ID: 37874501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial Dysfunction as a Factor of Energy Metabolism Disorders in Type 2 Diabetes Mellitus.
    Blagov A; Nedosugova L; Kirichenko T; Sukhorukov V; Melnichenko A; Orekhov A
    Front Biosci (Schol Ed); 2024 Mar; 16(1):5. PubMed ID: 38538341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis.
    Pinti MV; Fink GK; Hathaway QA; Durr AJ; Kunovac A; Hollander JM
    Am J Physiol Endocrinol Metab; 2019 Feb; 316(2):E268-E285. PubMed ID: 30601700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.